4
Changes in Ownership
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-21-015655
Corporate Executive VP & CFO sold 3,305 shares at $340.01 ($1,123,718)
- Corporate Executive VP & CFO acquired 3,305 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Smith David Ross Corporate Executive VP & CFO | 2021-05-04 | Option exercise | +3,305 | $144.67 | $478,134 | 18,167 | D |
| Smith David Ross Corporate Executive VP & CFO | 2021-05-04 | Sale | −3,305 | $340.01 | $1,123,718 | 14,862 | D |
| Derivatives | |||||||
| Smith David Ross Corporate Executive VP & CFO | 2021-05-04 | Option exercise · Stock Options (Right to Buy) | −3,305 | 6,609 | D | ||
| Open-market sales · 3,305 sh · avg $340.01 · $1,123,718 | |||||||
Loading xslF345X03/form4.xml…